The impact of dose reduction and time delay in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer.
Naoki Mashita
No relevant relationships to disclose
Goro Nakayama
No relevant relationships to disclose
Naomi Hayashi
No relevant relationships to disclose
Chie Tanaka
No relevant relationships to disclose
Daisuke Kobayashi
No relevant relationships to disclose
Mitsuro Kanda
No relevant relationships to disclose
Suguru Yamada
No relevant relationships to disclose
Tsutomu Fujii
No relevant relationships to disclose
Hiroyuki Sugimoto
No relevant relationships to disclose
Masahiko Koike
No relevant relationships to disclose
Shuji Nomoto
No relevant relationships to disclose
Michitaka Fujiwara
No relevant relationships to disclose
Yuichi Ando
No relevant relationships to disclose
Yasuhiro Kodera
No relevant relationships to disclose